HPHS Session at ECP 2023

Sept 13, 8.30-12PM (Irish Standard Time), Rm: Leffey B

Morphomolecular-driven management of liver tumors

Molecular subtypes of HCA: when to test? Valérie Paradis, Hospital Beaujon, Paris, France

Genetic drivers of cholangiocarcinoma and their impact on clinical management. Maria Isabel Fiel, Mount Sinai Health System, Icahn School of Medicine, New York, USA

Beyond the morpho-molecular classification of hepatocellular carcinoma. Julien Calderaro Henri Mondor, Pathology, Creteil, Île-de-France, France

Mesenchymal tumors of the liver: Any role for molecular pathology? Michael Torbenson, Mayo Clinic Rochester, Dept. of Pathology, Rochester, MN, USA

Liquid biopsy approaches in tailoring the treatment of liver tumors. Luigi Terracciano, Humanitas Research Hospital, Head of Anatomic Pathology Unit, Milan, Italy